Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency

G Lanzolla, E Sabini, K Beigel, MP Khan… - Proceedings of the …, 2024 - pnas.org
Estrogen deficiency, which is linked to various pathological conditions such as primary
ovarian insufficiency and postmenopausal osteoporosis, disrupts the delicate balance …

[HTML][HTML] Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health

LL Wang, ZJ Lu, SK Luo, Y Li, Z Yang… - World Journal of Stem …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Osteoporosis (OP) has become a major public health problem worldwide.
Most OP treatments are based on the inhibition of bone resorption, and it is necessary to …

Pathogenesis of late normal tissue effects

L Barazzuol, P van Luijk, RP Coppes… - Basic Clinical …, 2025 - taylorfrancis.com
Large efforts have been made to optimize the conformation of the treatment fields to the
tumor by advances in both imaging and radiotherapy technologies. However, administering …

[PDF][PDF] WJSC

Z Wang, C Feng, H Liu, T Meng, WQ Huang… - Stem …, 2023 - pdfs.semanticscholar.org
BACKGROUND Osteoporosis (OP) has become a major public health problem worldwide.
Most OP treatments are based on the inhibition of bone resorption, and it is necessary to …